News Updates
More Articles
- Solving the Challenge of Limited Data: Bayesian Statistics to the Rescue in Rare Disease Drug Development
- The Female Data Deficit: How Drug Development Still Fails Women
- China’s Out-Licensing Deals Bear Fruit in 2025
- From Paper to Digital: The Evolution of Electronic Product Information and the LatAm Playbook Experience
- The Hidden Governance Gap in Modern Clinical Trials
The Female Data Deficit: How Drug Development Still Fails Women
The Female Data Deficit: How Drug Development Still Fails Women
As drug development continues to rely on evidence disproportionately generated from male participants, the result is a persistent female data deficit that affects safety, dosing, efficacy, and trust.
×
